Snapshot
The global Non-steroidal Anti-inflammatory Drugs (NSAID) market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Non-steroidal Anti-inflammatory Drugs (NSAID) by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Glaxo Smith Kline
Johnson & Johnson
Bayer
Novacap
Abbott
Pfizer
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
Reddy Pharmaceuticals
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Back Pain Treatment
Osteoarthritis Treatment
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Non-steroidal Anti-inflammatory Drugs (NSAID)
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Non-steroidal Anti-inflammatory Drugs (NSAID)
1.2.2 Downstream
Table Application Segment of Non-steroidal Anti-inflammatory Drugs (NSAID)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Type
3.1 By Type
3.1.1 Aspirin
Table Major Company List of Aspirin
3.1.2 Ibuprofen
Table Major Company List of Ibuprofen
3.1.3 Naproxen
Table Major Company List of Naproxen
3.1.4 Nabumetone
Table Major Company List of Nabumetone
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2016-2020, by Type, in USD Million
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Growth 2016-2020, by Type, in USD Million
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2016-2020, by Type, in Volume
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast 2021-2026, by Type, in USD Million
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Glaxo Smith Kline (Company Profile, Sales Data etc.)
4.1.1 Glaxo Smith Kline Profile
Table Glaxo Smith Kline Overview List
4.1.2 Glaxo Smith Kline Products & Services
4.1.3 Glaxo Smith Kline Business Operation Conditions
Table Business Operation of Glaxo Smith Kline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Johnson & Johnson (Company Profile, Sales Data etc.)
4.2.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
4.2.2 Johnson & Johnson Products & Services
4.2.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Bayer (Company Profile, Sales Data etc.)
4.3.1 Bayer Profile
Table Bayer Overview List
4.3.2 Bayer Products & Services
4.3.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Novacap (Company Profile, Sales Data etc.)
4.4.1 Novacap Profile
Table Novacap Overview List
4.4.2 Novacap Products & Services
4.4.3 Novacap Business Operation Conditions
Table Business Operation of Novacap (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Abbott (Company Profile, Sales Data etc.)
4.5.1 Abbott Profile
Table Abbott Overview List
4.5.2 Abbott Products & Services
4.5.3 Abbott Business Operation Conditions
Table Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Pfizer (Company Profile, Sales Data etc.)
4.6.1 Pfizer Profile
Table Pfizer Overview List
4.6.2 Pfizer Products & Services
4.6.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Geri-Care Pharmaceuticals (Company Profile, Sales Data etc.)
4.7.1 Geri-Care Pharmaceuticals Profile
Table Geri-Care Pharmaceuticals Overview List
4.7.2 Geri-Care Pharmaceuticals Products & Services
4.7.3 Geri-Care Pharmaceuticals Business Operation Conditions
Table Business Operation of Geri-Care Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Perrigo Company (Company Profile, Sales Data etc.)
4.8.1 Perrigo Company Profile
Table Perrigo Company Overview List
4.8.2 Perrigo Company Products & Services
4.8.3 Perrigo Company Business Operation Conditions
Table Business Operation of Perrigo Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Kopran (Company Profile, Sales Data etc.)
4.9.1 Kopran Profile
Table Kopran Overview List
4.9.2 Kopran Products & Services
4.9.3 Kopran Business Operation Conditions
Table Business Operation of Kopran (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Merck Sharp & Dohme (Company Profile, Sales Data etc.)
4.10.1 Merck Sharp & Dohme Profile
Table Merck Sharp & Dohme Overview List
4.10.2 Merck Sharp & Dohme Products & Services
4.10.3 Merck Sharp & Dohme Business Operation Conditions
Table Business Operation of Merck Sharp & Dohme (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Sun Pharmaceutical Industries (Company Profile, Sales Data etc.)
4.11.1 Sun Pharmaceutical Industries Profile
Table Sun Pharmaceutical Industries Overview List
4.11.2 Sun Pharmaceutical Industries Products & Services
4.11.3 Sun Pharmaceutical Industries Business Operation Conditions
Table Business Operation of Sun Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Reddy Pharmaceuticals (Company Profile, Sales Data etc.)
4.12.1 Reddy Pharmaceuticals Profile
Table Reddy Pharmaceuticals Overview List
4.12.2 Reddy Pharmaceuticals Products & Services
4.12.3 Reddy Pharmaceuticals Business Operation Conditions
Table Business Operation of Reddy Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Revenue 2016-2020, by Company, in USD Million
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Revenue Share in 2020, by Company, in USD Million
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume 2016-2020, by Company, in Volume
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration, in 2020
Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Market Concentration, in 2020
Figure Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) MMarket Concentration, in 2020
Figure South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration, in 2020
Figure Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Back Pain Treatment
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Demand in Back Pain Treatment, 2016-2020, in USD Million
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Demand in Back Pain Treatment, 2016-2020, in Volume
6.1.2 Demand in Osteoarthritis Treatment
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Demand in Osteoarthritis Treatment, 2016-2020, in USD Million
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Demand in Osteoarthritis Treatment, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Demand in Others, 2016-2020, in USD Million
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Demand Forecast 2021-2026, by Application, in USD Million
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Market Growth 2021-2026, by Application, in USD Million
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share in 2026, by Application, in USD Million
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Demand Forecast 2021-2026, by Application, in Volume
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Market Growth 2021-2026, by Application, in Volume
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Production 2016-2020, by Region, in USD Million
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2016-2020, by Region, in USD Million
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share 2016-2020, by Region, in USD Million
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2016-2020, by Region, in Volume
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in USD Million
Figure North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in USD Million
Table North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in USD Million
Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in USD Million
Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in USD Million
Figure South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in USD Million
Table South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast 2021-2026, by Region, in USD Million
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
1. Table Upstream Segment of Non-steroidal Anti-inflammatory Drugs (NSAID)
2. Table Application Segment of Non-steroidal Anti-inflammatory Drugs (NSAID)
3. Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Ibuprofen
5. Table Major Company List of Naproxen
6. Table Major Company List of Nabumetone
7. Table Major Company List of Others
8. Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2016-2020, by Type, in USD Million
9. Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2016-2020, by Type, in Volume
10. Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast 2021-2026, by Type, in USD Million
11. Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast 2021-2026, by Type, in Volume
12. Table Glaxo Smith Kline Overview List
13. Table Business Operation of Glaxo Smith Kline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Johnson & Johnson Overview List
15. Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Bayer Overview List
17. Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Novacap Overview List
19. Table Business Operation of Novacap (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Abbott Overview List
21. Table Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Pfizer Overview List
23. Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Geri-Care Pharmaceuticals Overview List
25. Table Business Operation of Geri-Care Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Perrigo Company Overview List
27. Table Business Operation of Perrigo Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table Kopran Overview List
29. Table Business Operation of Kopran (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table Merck Sharp & Dohme Overview List
31. Table Business Operation of Merck Sharp & Dohme (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
32. Table Sun Pharmaceutical Industries Overview List
33. Table Business Operation of Sun Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
34. Table Reddy Pharmaceuticals Overview List
35. Table Business Operation of Reddy Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
36. Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Revenue 2016-2020, by Company, in USD Million
37. Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Revenue Share 2016-2020, by Company, in USD Million
38. Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume 2016-2020, by Company, in Volume
39. Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share 2016-2020, by Company, in Volume
40. Table Regional Demand Comparison List
41. Table Major Application in Different Regions
42. Table Non-steroidal Anti-inflammatory Drugs (NSAID) Demand Forecast 2021-2026, by Application, in USD Million
43. Table Non-steroidal Anti-inflammatory Drugs (NSAID) Demand Forecast 2021-2026, by Application, in Volume
44. Table Non-steroidal Anti-inflammatory Drugs (NSAID) Market Growth 2021-2026, by Application, in Volume
45. Table Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share in 2026, by Application, in Volume
46. Table Non-steroidal Anti-inflammatory Drugs (NSAID) Production 2016-2020, by Region, in USD Million
47. Table Non-steroidal Anti-inflammatory Drugs (NSAID) Production 2016-2020, by Region, in Volume
48. Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2016-2020, by Region, in USD Million
49. Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share 2016-2020, by Region, in USD Million
50. Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2016-2020, by Region, in Volume
51. Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share 2016-2020, by Region, in Volume
52. Table North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in USD Million
53. Table North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in Volume
54. Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in USD Million
55. Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in Volume
56. Table Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in USD Million
57. Table Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in Volume
58. Table South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in USD Million
59. Table South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in Volume
60. Table Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in USD Million
61. Table Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2016-2020, by Country, in Volume
62. Table Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast 2021-2026, by Region, in USD Million
63. Table Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast 2021-2026, by Region, in Volume
64. Table Price Factors List
List of Figure
1. Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Chain Structure
2. Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Growth 2016-2020, by Type, in Volume
4. Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration, in 2020
7. Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Market Concentration, in 2020
8. Figure Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) MMarket Concentration, in 2020
9. Figure South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration, in 2020
10. Figure Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration, in 2020
11. Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Demand in Back Pain Treatment, 2016-2020, in USD Million
12. Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Demand in Back Pain Treatment, 2016-2020, in Volume
13. Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Demand in Osteoarthritis Treatment, 2016-2020, in USD Million
14. Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Demand in Osteoarthritis Treatment, 2016-2020, in Volume
15. Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Demand in Others, 2016-2020, in USD Million
16. Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Demand in Others, 2016-2020, in Volume
17. Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Market Growth 2021-2026, by Application, in USD Million
18. Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share in 2026, by Application, in USD Million
19. Figure North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in USD Million
20. Figure North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in Volume
21. Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in USD Million
22. Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in Volume
23. Figure Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in USD Million
24. Figure Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in Volume
25. Figure South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in USD Million
26. Figure South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in Volume
27. Figure Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in USD Million
28. Figure Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth 2016-2020, in Volume
29. Figure Marketing Channels Overview
